Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
3-?[5-?(5-?Chloro-?2-?ethoxyphenyl)?-?1,?3,?4-?oxadiazol-?2-?yl]?-?N-?(2,?3-?dihydro-?1,?5-?dimethyl-?3-?oxo-?2-?phenyl-?1H-?pyrazol-?4-?yl)?-cyclohexanecarboxami?de is a pyrazolone derivative used in the treatment of cancer, leukemia, lymphoma and other diseases.